e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Autolus Therapeutics plc - American Depositary Shares (NQ:AUTL)

1.210 -0.080 (-6.20%)

Streaming Delayed Price Updated: 9:30 AM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Autolus Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Autolus Therapeutics Stock Jumps After Bristol Myers Pact For Safety Switch System ↗

October 04, 2022

Via Benzinga

Autolus Therapeutics Announces Collaboration with Bristol Myers Squibb for Use of Autolus’ Proprietary Safety Switch System

October 04, 2022

From Autolus Therapeutics plc

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 21, 2022

Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.

Via Benzinga

Recap: Autolus Therapeutics Q2 Earnings ↗

August 04, 2022

Autolus Therapeutics (NASDAQ:AUTL) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study ↗

May 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

Recap: Autolus Therapeutics Q4 Earnings ↗

March 10, 2022

Autolus Therapeutics (NASDAQ:AUTL) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

December 13, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

58 Biggest Movers From Yesterday ↗

December 14, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...

Via Benzinga

Why Autolus Therapeutics Stock Jumped 25% Today ↗

November 08, 2021

A private equity firm is taking a $100 million stake in the biotech.

Via The Motley Fool

Mid-Afternoon Market Update: eHealth Drops Following Q3 Results; Autolus Therapeutics Shares Gain ↗

November 08, 2021

Toward the end of trading Monday, the Dow traded up 0.12% to 36,372.57 while the NASDAQ rose 0.23% to 16,009.02. The S&P also rose, gaining 0.07% to 4,700.74. The U.S. has the...

Via Benzinga

Topics Stocks

64 Biggest Movers From Yesterday ↗

November 09, 2021

Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares jumped 219% to close at $10.40 on Monday after the company announced the launch of its E-Boost portfolio of mobile...

Via Benzinga

Mid-Day Market Update: Trade Desk Jumps After Upbeat Results; GT Biopharma Shares Slide ↗

November 08, 2021

Midway through trading Monday, the Dow traded up 0.34% to 36,452.79 while the NASDAQ rose 0.18% to 16,000.97. The S&P also rose, gaining 0.11% to 4,702.76. The U.S. has the...

Via Benzinga

Topics Stocks

38 Stocks Moving In Monday's Mid-Day Session ↗

November 08, 2021

Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares climbed 129.8% to $7.49 after the company announced the launch of its E-Boost portfolio of mobile Electric Vehicle...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 08, 2021

Gainers PetVivo Holdings (NASDAQ:PETV) s...

Via Benzinga

DSAC Stock Pops on FiscalNote SPAC Merger News. 14 Things to Know. ↗

November 08, 2021

Duddell Street Acquisition (DSAC) stock is on the move Monday following news of a special purpose acquisition company merger with FiscalNote.

Via InvestorPlace

Chinese Stocks Alert: The Turnaround Story Driving TAL, EDU, METX, GOTU Stocks Higher ↗

November 08, 2021

Chinese education stocks are moving higher on Monday as reports claim China will allow companies to resume their after-school tutoring.

Via InvestorPlace

AUTL Stock: Why Little-Known Autolus Therapeutics Is Rocketing Higher Today ↗

November 08, 2021

Autolus Therapeutics (AUTL) stock is surging higher in trading Monday following news of a major investment in the company.

Via InvestorPlace

Mid-Morning Market Update: Markets Rise; Coty Posts Upbeat Earnings ↗

November 08, 2021

Following the market opening Monday, the Dow traded up 0.40% to 36,472.70 while the NASDAQ rose 0.20% to 16,003.39. The S&P also rose, gaining 0.15% to 4,704.42. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 08, 2021

Gainers Autolus Therapeutics (NASDAQ:AUTL) stock rose 21.04% to $6.73 during Monday's pre-market session. The company's market cap stands at $490.7 million. As per...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 08, 2021

Welcome back, trader! We're starting off the week strong with a dive into the biggest pre-market stock movers for Monday.

Via InvestorPlace

26 Stocks Moving in Monday's Pre-Market Session ↗

November 08, 2021

Gainers Autolus Therapeutics plc (NASDAQ: AUTL) rose 32.6% to $7.37 in pre-market trading. Syncona said Blackstone Life Science will invest $250 million in Autolus. Mainz Biomed...

Via Benzinga

Autolus Stock Rallies On $250M Investment From Blackstone ↗

November 08, 2021

Blackstone Inc (NYSE: BX) will invest $250 million in Autolus Therapeutics plc (NASDAQ: AUTL) to fund the final stages of developing a new therapy to...

Via Benzinga

Allogene Craters To 52-Week Low On FDA Clinical Hold Of CAR-T Trials, Drags Peers As Well ↗

October 08, 2021

The FDA has sent shockwaves through the off-the-shelf CAR-T space after it slapped a clinical hold on all of the Allogene Therapeutics Inc (NASDAQ: ALLO)...

Via Benzinga

Autolus' Blood Cancer CAR T-Cell Therapy Receives Promising Innovative Medicine In UK ↗

August 09, 2021

The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has granted Promising Innovative Medicine (PIM) designation to Autolus Therapeutics plc's...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 02, 2021

Gainers Xenetic Biosciences (NASDAQ:XBIO) stock increased by 35.01% to $5.5 during Monday's regular session. Trading volume for Xenetic Biosciences's stock is 10.1...

Via Benzinga

Here's Why Autolus Therapeutics Is Surging Today ↗

August 02, 2021

Potential licensing agreements with Moderna are giving investors reasons to cheer.

Via The Motley Fool

Autolus Stock Jumps On Cancer mRNA Therapeutics Agreement With Moderna ↗

August 02, 2021

Autolus Therapeutics plc (NASDAQ: AUTL) has granted Moderna Inc (NASDAQ: MRNA) an exclusive license to develop and commercialize mRNA therapeutics...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy